52.37
price up icon4.61%   2.31
after-market アフターアワーズ: 52.46 0.09 +0.17%
loading
前日終値:
$50.06
開ける:
$50.33
24時間の取引高:
976.87K
Relative Volume:
1.03
時価総額:
$2.04B
収益:
-
当期純損益:
$-63.78M
株価収益率:
-19.54
EPS:
-2.68
ネットキャッシュフロー:
$-53.91M
1週間 パフォーマンス:
+18.51%
1か月 パフォーマンス:
+284.23%
6か月 パフォーマンス:
+314.98%
1年 パフォーマンス:
+211.36%
1日の値動き範囲:
Value
$49.50
$53.40
1週間の範囲:
Value
$42.88
$53.40
52週間の値動き範囲:
Value
$7.575
$53.40

Celcuity Inc Stock (CELC) Company Profile

Name
名前
Celcuity Inc
Name
セクター
Healthcare (1161)
Name
電話
763-392-0767
Name
住所
16305 36TH AVENUE N, MINNEAPOLIS, MN
Name
職員
87
Name
Twitter
Name
次回の収益日
2025-03-31
Name
最新のSEC提出書
Name
CELC's Discussions on Twitter

CELC を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CELC
Celcuity Inc
52.37 1.92B 0 -63.78M -53.91M -2.68
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.92 96.01B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.55 57.86B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
432.52 57.02B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
646.60 39.10B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
307.51 34.45B 3.81B -644.79M -669.77M -6.24

Celcuity Inc Stock (CELC) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-01 再開されました Stifel Buy
2024-07-22 開始されました Leerink Partners Outperform
2024-02-22 開始されました Stifel Buy
2023-12-08 開始されました H.C. Wainwright Buy
2021-10-08 開始されました Canaccord Genuity Buy
2021-09-07 開始されました Jefferies Buy
2021-07-29 開始されました Cowen Outperform
2021-07-27 開始されました Needham Buy
2021-01-28 繰り返されました H.C. Wainwright Buy
2020-12-24 繰り返されました H.C. Wainwright Buy
2020-05-11 再開されました Craig Hallum Buy
2018-11-20 開始されました H.C. Wainwright Buy
すべてを表示

Celcuity Inc (CELC) 最新ニュース

pulisher
Aug 12, 2025

Celcuity announces $225M combined offerings; shares down - MSN

Aug 12, 2025
pulisher
Aug 11, 2025

Celcuity CELC 2025Q2 Earnings Preview Upside Potential on Positive Clinical Trial Results - AInvest

Aug 11, 2025
pulisher
Aug 10, 2025

Celcuity (CELC) Is Up 15.0% After Positive Phase 3 Results and $260 Million Capital Raise – Has The Bull Case Changed? - simplywall.st

Aug 10, 2025
pulisher
Aug 08, 2025

Celcuity stock hits all-time high at 46.52 USD By Investing.com - Investing.com Nigeria

Aug 08, 2025
pulisher
Aug 08, 2025

Celcuity stock hits all-time high at 46.52 USD - Investing.com

Aug 08, 2025
pulisher
Aug 08, 2025

Celcuity Inc expected to post a loss of 88 cents a shareEarnings Preview - TradingView

Aug 08, 2025
pulisher
Aug 07, 2025

Celcuity Inc. Schedules Release of Second Quarter 2025 Financial Results and Webcast/Conference Call - The Manila Times

Aug 07, 2025
pulisher
Aug 07, 2025

Celcuity Announces Q2 2025 Earnings Date: Biotech's Financial Results and Conference Call Details Revealed - Stock Titan

Aug 07, 2025
pulisher
Aug 07, 2025

Celcuity Announces Q2 2025 Financial Results and Webcast/Conference Call on August 14, 2025. - AInvest

Aug 07, 2025
pulisher
Aug 06, 2025

Celcuity Inc. shares rise 3.71% intraday as Novartis considers deal for biotech Avidity Biosciences. - AInvest

Aug 06, 2025
pulisher
Aug 05, 2025

Celcuity Inc. shares fall 2.09% premarket after insider sells $4.82 million in stock. - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

Celcuity’s Promising Clinical Trial Results and Strong Buy Recommendation by Andrew Berens - TipRanks

Aug 05, 2025
pulisher
Aug 04, 2025

Celcuity Inc. Stock Analysis and ForecastCapitalize on market momentum for maximum gains - Jammu Links News

Aug 04, 2025
pulisher
Aug 03, 2025

What drives Celcuity Inc. stock priceMaximize gains with expert analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Celcuity Inc. in the next 12 monthsNavigate the market with precision tools - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the technical indicators suggesting about Celcuity Inc.Unlock exclusive trading strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Celcuity Inc. stockPhenomenal returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Celcuity Inc. stock in 2025Get expert analysis on top stock picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Celcuity Inc. compare to its industry peersRapid return acceleration - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Is it the right time to buy Celcuity Inc. stockBuild a winning investment portfolio - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Why is Celcuity Inc. stock attracting strong analyst attentionAchieve rapid wealth accumulation through smart investing - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What markets is Celcuity Inc. expanding into Is GSUN stock a good long term investment option - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Celcuity Completes $201.25 Million Convertible Notes Issuance - MSN

Aug 02, 2025
pulisher
Aug 02, 2025

What is the dividend policy of Celcuity Inc. stockExceptional risk-adjusted gains - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

What institutional investors are buying Celcuity Inc. stockSwing Trade Outlook For Every Investor - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

Celcuity Raises $248.7 Million Through Stock and Notes - The Globe and Mail

Aug 01, 2025
pulisher
Jul 31, 2025

Celcuity Inc. stock trend outlook and recovery pathMarket Momentum Signal Generator Shows Trends - metal.it

Jul 31, 2025
pulisher
Jul 31, 2025

Celcuity Inc. shares fall 1.57% after-hours as Novartis' Leqvio® receives FDA label update. - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

Celcuity Inc's Recent Stock Offering: A Strategic Move in the Biotech Sector - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

How strong is Celcuity Inc. company’s balance sheetSmart Portfolio Data Feed For 2025 - Jammu Links News

Jul 31, 2025
pulisher
Jul 31, 2025

Celcuity prices $248.7M debt, stock offerings - MSN

Jul 31, 2025
pulisher
Jul 31, 2025

Insiders Favor These 3 High Growth Companies - Yahoo Finance

Jul 31, 2025
pulisher
Jul 30, 2025

Celcuity Inc. shares fall 1.24% after-hours following Novartis Canada's Scemblix approval expansion. - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Celcuity Surges 4.68% on $423.7M Capital Raise as $250M Volume Ranks 486th - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Dalvey David sells Celcuity (CELC) stock worth $4.8 million - Investing.com Australia

Jul 30, 2025
pulisher
Jul 30, 2025

Dalvey David sells Celcuity (CELC) stock worth $4.8 million By Investing.com - Investing.com India

Jul 30, 2025
pulisher
Jul 30, 2025

Celcuity: Positive Phase 3 Wild-Type ABC Data With Gedatolisib Leads To End Of 2025 Catalyst - Seeking Alpha

Jul 30, 2025
pulisher
Jul 30, 2025

Celcuity Inc. Announces Pricing of Concurrent Public - GlobeNewswire

Jul 30, 2025
pulisher
Jul 30, 2025

Celcuity (CELC) Is Up 176.2% After Positive Phase 3 Breast Cancer Results — Has the Bull Case Changed? - simplywall.st

Jul 30, 2025
pulisher
Jul 30, 2025

Celcuity Prices Public Offering Of 175 Mln, 2.75% Sr. Notes, And 1.84 Mln Shares At $38/Shr - Nasdaq

Jul 30, 2025
pulisher
Jul 30, 2025

Celcuity prices $175 million convertible notes, $85 million stock offering - Investing.com Australia

Jul 30, 2025
pulisher
Jul 30, 2025

Celcuity prices $175 million convertible notes, $85 million stock offering By Investing.com - Investing.com India

Jul 30, 2025

Celcuity Inc (CELC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$36.46
price up icon 1.67%
$85.87
price up icon 5.22%
$26.86
price up icon 4.59%
$122.87
price up icon 0.71%
$112.78
price up icon 1.60%
biotechnology ONC
$307.51
price up icon 6.74%
大文字化:     |  ボリューム (24 時間):